In last trading session, TransMedics Group Inc. (NASDAQ:TMDX) saw 1,450,045 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $24.96 trading at -$3.11 or -11.08% at ring of the bell on the day assigns it a market valuation of $689.47 Million. That closing price of TMDX’s stock is at a discount of -98.32% from its 52-week high price of $49.5 and is indicating a premium of 53.89% from its 52-week low price of $11.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 360.64 Million shares which gives us an average trading volume of 1Million if we extend that period to 3-months.